Automation can offer labs a vast range of benefits, from improving productivity and accuracy to enabling researchers to focus on less menial tasks. Despite this potential, many labs are hesitant to ...

Most people still picture science as a person in a white coat, pipette in hand. That image is stubbornly accurate. Even in 2025—after decades of lab robots, high‑throughput screening, and cloud ...

Cell therapies are among the most promising, yet complex medicines being developed today. Multiply Labs' mission is to make these therapies more widely available by increasing manufacturing efficiency ...

INTEGRA Biosciences is inviting labs to leave manual pipetting behind and take their first steps into effortless automation with a new Lab Evolution competition for 2026. One forward-thinking ...

Robotic biomanufacturing company Multiply Labs said it has made a significant advance toward its goal of scaling production of cell and gene therapies by using Nvidia’s open Isaac and GR00T robotics ...

Collaboration with AstraZeneca will focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic biomanufacturing technology SAN FRANCISCO--(BUSINESS WIRE)--#AstraZeneca--Multiply ...

A competition calling for research projects involving so-called AI scientists shows just how fast this technology is moving. A number of startups and university teams that are building “AI scientists” ...